Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
SSymBio Pharmaceuticals Limited logo
4582TSE Growth

SymBio Pharmaceuticals Limited

シンバイオ製薬 Yahoo Finance

Recent & upcoming events

Aug 10
Earnings 2:00
Q2 earnings announcement (scheduled)
Add to Google Calendar
May 7
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Mar 23
Shareholder meeting 21:00
Shareholders' meeting
Venue: サピアタワー5階 東京都千代田区丸の内一丁目7番12号 Details
Add to Google Calendar
Feb 5
Earnings 1:00
FY earnings announcement (scheduled)
Add to Google Calendar
Nov 12
Est.
Earnings 1:00 approx.
Q3 earnings
Add to Google Calendar
2027
Feb 11
Est.
Earnings 1:00 approx.
Full-year earnings
Add to Google Calendar
May 13
Est.
Earnings 2:00 approx.
Q1 earnings
Add to Google Calendar
Aug 12
Est.
Earnings 2:00 approx.
Q2 earnings
Add to Google Calendar

KPI highlights

FY25
Revenue ¥1.31B YoY -46.7%
Operating income ¥-4.44B margin -339.6%
Net income ¥-4.78B YoY —
EPS ¥-95 YoY —
P/E —
ROE —

Company guidance

FY2026/12 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥3.89B +197.6%
Operating income ¥-4.23B —
Net income ¥-4.33B —
EPS ¥-73 —

Quarterly fundamentals

Income & cash flow
Quarter FY24 Q4FY25 Q1FY25 Q2FY25 Q3FY25 Q4FY26 Q1
Revenue ¥555M¥264M¥383M¥324M¥337M—
Operating income ¥-1.09B¥-1.17B¥-985M¥-1.19B¥-1.10B—
Net income ¥-988M¥-1.32B¥-1.05B¥-1.20B¥-1.21B—
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2020–2025）

国内機関 6.2%個人 4.9%未開示 86.5%202020212022202320242025
事業法人国内機関海外機関個人未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

吉田　文紀 2.8%吉田　文紀楽天証券株式会社共有口 2.4%楽天証券株式会社共有口株式会社SBI証券 2.3%株式会社SBI証券MORGAN STANLEY ＆ C 1.6%MORGAN STANLEY ＆ CO. LLC（常任代理人　モルガン・スタンレーMUFG証券株式会社）JPモルガン証券株式会社 0.9%JPモルガン証券株式会社STATE STREET BANK 0.9%STATE STREET BANK AND TRUST COMPANY 510643（常任代理人　株式会社みずほ銀行決済営業部）陳元 0.8%陳元村山　信也 0.7%村山　信也木下　みどり 0.6%木下　みどり日本証券金融株式会社 0.5%日本証券金融株式会社202020212022202320242025

Top shareholders — actual figures (as of 2025)

Holder Shares held Ratio Source
吉田 文紀 1,684,200 2.8% Yuho (EDINET)
楽天証券株式会社共有口 1,414,000 2.4% Yuho (EDINET)
株式会社SBI証券 1,384,480 2.3% Yuho (EDINET)
MORGAN STANLEY ＆ CO. LLC 951,028 1.6% Yuho (EDINET)
JPモルガン証券株式会社 542,472 0.9% Yuho (EDINET)
STATE STREET BANK AND TRUST COMPANY 510643 512,000 0.9% Yuho (EDINET)
陳元 466,800 0.8% Yuho (EDINET)
村山 信也 402,200 0.7% Yuho (EDINET)
木下 みどり 336,000 0.6% Yuho (EDINET)
日本証券金融株式会社 313,900 0.5% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

1/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✗ Positive ROA ROA -123.5%
✗ Positive operating cash flow ¥-4.58B
✗ ROA improved YoY -77.2% → -123.5%
✓ Operating CF exceeds net income (accrual quality) OCF ¥-4.58B / net income ¥-4.78B
✗ Equity ratio improved* Substitute for the original “decrease in long-term debt” 78.1% → 23.9%
✗ Current ratio improved 6.43× → 2.96×
✗ No dilution (shares outstanding did not increase) 45,928,856 → 59,567,080
✗ Gross margin improved 76.4% → 72.4%
✗ Asset turnover improved 0.49× → 0.34×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY25
Equity ratio 23.9%
Current ratio 3.0×
Years of positive operating CF 2 of last 6 yrs
Payout ratio —
Latest fiscal year result Loss (net loss ¥4.78B)

Performance history

Last 10 years
0億円25億円50億円75億円100億円 FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

Income & assets

Unit: ¥100M
Item FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Revenue 23.734.438.428.429.982.610055.924.513.1
Operating income -21.3-39.5-26.6-43.0-45.110.219.6-8.12-38.8-44.4
Ordinary income -23.2-39.8-27.5-43.8-46.210.020.0-7.36-36.9-46.5
Net income -23.1-39.8-27.5-43.8-40.920.311.8-19.6-38.3-47.8
Total assets 68.842.562.452.762.784.510481.749.738.7
Equity 54.832.449.044.046.667.585.172.142.012.7

Indicators & cash flow

Unit: ¥100M
Item FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
EPS ————¥-124¥52¥30¥-49¥-85¥-95
ROE ——————14.6%———
Operating CF ————-53.06.6716.1-1.95-34.2-45.8
Investing CF ————-0.27-0.32-0.47-3.77-0.04-0.76
Financing CF ————42.2-0.726.286.807.0836.2
FCF ————-42.70.7615.7-5.71-34.2-46.5

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Sector positioning

Relative standing within the sector

IR disclosure history

Timely disclosures & annual reports
Is this information incorrect?

Data provided by Twelve Data